Well tbh I think they issue less groundbreaking PRs to stabilize the stock while they make progress in the many different avenues that they are in. One solid piece of PR would be a biopsy report and progress pictures of additional patients who are healing their cancer using cannabis oil. Another solid piece of PR would be a positive report of the pre-IND meeting with the FDA. Yet another would be progress in the preproduction of the documentary. The last PR already gave us much more information on what will actually be contained in the documentary, and the novel approach they will take, so I thought it was decent news.
Btw, don't let yourself be fooled too much by the bashers calling everything "fluff PR". Sure, it's not always groundbreaking, but in many cases it is progress and new information on previously issued PRs, albeit a bit slow (which is understandable considering the difficulties in this industry). Don't let the fact that they are exploring many different interesting avenues make you believe that this means nothing. If you know the CEO, COO and many other CBIS personnel, along with the scientific basis for their industry, you know they would not resort to "smoke and mirror" tactics.
Don't get caught in the hyperbolic daytrader rhythm. They seem to demand huge progress every day and huge breakthroughs in every avenue. That's just not realistic. They just try to sow doubt, fear and misunderstanding among others so they can profit.
Market Data 
Markets 
AI
